A novel variant of THRβ and its 4-year clinical course in a Korean boy with resistance to thyroid hormone

Thyroid hormone resistance (RTH) is characterized by a decreased sensitivity of target tissues to thyroid hormones due to a defect in the THRα- and THRβ-encoded thyroid hormone receptors (THRs). The clinical manifestations range from no symptoms to simple goiter and hypo- or hyperthyroidism, dependi...

Full description

Bibliographic Details
Main Authors: Sejin Kim, Soyun Park, Jungeun Moon, Heungsik Kim, Seokjin Kang
Format: Article
Language:English
Published: Korean Society of Pediatric Endocrinology 2023-09-01
Series:Annals of Pediatric Endocrinology & Metabolism
Subjects:
Online Access:http://e-apem.org/upload/pdf/apem-2142246-123.pdf
_version_ 1797672799214501888
author Sejin Kim
Soyun Park
Jungeun Moon
Heungsik Kim
Seokjin Kang
author_facet Sejin Kim
Soyun Park
Jungeun Moon
Heungsik Kim
Seokjin Kang
author_sort Sejin Kim
collection DOAJ
description Thyroid hormone resistance (RTH) is characterized by a decreased sensitivity of target tissues to thyroid hormones due to a defect in the THRα- and THRβ-encoded thyroid hormone receptors (THRs). The clinical manifestations range from no symptoms to simple goiter and hypo- or hyperthyroidism, depending on the receptor subtype distribution in the tissues. Here, we report the case of a thyroid hormone-resistant 12-month-old boy carrying a novel THRβ variant who was initially diagnosed with congenital hypothyroidism. An extensive evaluation revealed increased free T4 level and inappropriately increased thyroid-stimulating hormone (TSH) level; a normal lipid profile, sex hormone-binding globulin, and free alpha subunit of TSH; exaggerated TSH response to THR; and no radiological evidence of pituitary adenoma. A targeted next-generation sequencing panel identified a heterozygote c.993T>G (p.Asn331Lys) mutation in the THRβ gene. During the first year of life, a higher dose of levothyroxine was administered to the patient due to uncompensated RTH. Levothyroxine treatment was continued after 3 years to maintain TSH level <5 mIU/mL, but the observed weight gain was poor, height increase was insufficient, and bone development was delayed. However, neither hyperactivity nor developmental delay was observed. Patients with RTH exhibit various clinical features. Due to its heterogeneous nature, genetic test for accurate diagnosis is important to provide proper management.
first_indexed 2024-03-11T21:35:28Z
format Article
id doaj.art-13f770ed43f448bba7d661f1dafff44e
institution Directory Open Access Journal
issn 2287-1012
2287-1292
language English
last_indexed 2024-03-11T21:35:28Z
publishDate 2023-09-01
publisher Korean Society of Pediatric Endocrinology
record_format Article
series Annals of Pediatric Endocrinology & Metabolism
spelling doaj.art-13f770ed43f448bba7d661f1dafff44e2023-09-27T00:10:03ZengKorean Society of Pediatric EndocrinologyAnnals of Pediatric Endocrinology & Metabolism2287-10122287-12922023-09-0128321922410.6065/apem.2142246.123998A novel variant of THRβ and its 4-year clinical course in a Korean boy with resistance to thyroid hormoneSejin Kim0Soyun Park1Jungeun Moon2Heungsik Kim3Seokjin Kang4 Department of Pediatrics, Keimyung University Dongsan Hospital, Keimyung University school of Medicine, Daegu, Korea Department of Pediatrics, Keimyung University Dongsan Hospital, Keimyung University school of Medicine, Daegu, Korea Department of Pediatrics, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Korea Deparment of Pediatrics, Keimyung University Daegu Dongsan Hospital, Daegu, Korea Department of Pediatrics, Keimyung University Dongsan Hospital, Keimyung University school of Medicine, Daegu, KoreaThyroid hormone resistance (RTH) is characterized by a decreased sensitivity of target tissues to thyroid hormones due to a defect in the THRα- and THRβ-encoded thyroid hormone receptors (THRs). The clinical manifestations range from no symptoms to simple goiter and hypo- or hyperthyroidism, depending on the receptor subtype distribution in the tissues. Here, we report the case of a thyroid hormone-resistant 12-month-old boy carrying a novel THRβ variant who was initially diagnosed with congenital hypothyroidism. An extensive evaluation revealed increased free T4 level and inappropriately increased thyroid-stimulating hormone (TSH) level; a normal lipid profile, sex hormone-binding globulin, and free alpha subunit of TSH; exaggerated TSH response to THR; and no radiological evidence of pituitary adenoma. A targeted next-generation sequencing panel identified a heterozygote c.993T>G (p.Asn331Lys) mutation in the THRβ gene. During the first year of life, a higher dose of levothyroxine was administered to the patient due to uncompensated RTH. Levothyroxine treatment was continued after 3 years to maintain TSH level <5 mIU/mL, but the observed weight gain was poor, height increase was insufficient, and bone development was delayed. However, neither hyperactivity nor developmental delay was observed. Patients with RTH exhibit various clinical features. Due to its heterogeneous nature, genetic test for accurate diagnosis is important to provide proper management.http://e-apem.org/upload/pdf/apem-2142246-123.pdf thyroid hormone resistancethyroid hormone receptorlevothyroxineheterozygous mutationthyroid-stimulating hormone
spellingShingle Sejin Kim
Soyun Park
Jungeun Moon
Heungsik Kim
Seokjin Kang
A novel variant of THRβ and its 4-year clinical course in a Korean boy with resistance to thyroid hormone
Annals of Pediatric Endocrinology & Metabolism

thyroid hormone resistance
thyroid hormone receptor
levothyroxine
heterozygous mutation
thyroid-stimulating hormone
title A novel variant of THRβ and its 4-year clinical course in a Korean boy with resistance to thyroid hormone
title_full A novel variant of THRβ and its 4-year clinical course in a Korean boy with resistance to thyroid hormone
title_fullStr A novel variant of THRβ and its 4-year clinical course in a Korean boy with resistance to thyroid hormone
title_full_unstemmed A novel variant of THRβ and its 4-year clinical course in a Korean boy with resistance to thyroid hormone
title_short A novel variant of THRβ and its 4-year clinical course in a Korean boy with resistance to thyroid hormone
title_sort novel variant of thrβ and its 4 year clinical course in a korean boy with resistance to thyroid hormone
topic
thyroid hormone resistance
thyroid hormone receptor
levothyroxine
heterozygous mutation
thyroid-stimulating hormone
url http://e-apem.org/upload/pdf/apem-2142246-123.pdf
work_keys_str_mv AT sejinkim anovelvariantofthrbandits4yearclinicalcourseinakoreanboywithresistancetothyroidhormone
AT soyunpark anovelvariantofthrbandits4yearclinicalcourseinakoreanboywithresistancetothyroidhormone
AT jungeunmoon anovelvariantofthrbandits4yearclinicalcourseinakoreanboywithresistancetothyroidhormone
AT heungsikkim anovelvariantofthrbandits4yearclinicalcourseinakoreanboywithresistancetothyroidhormone
AT seokjinkang anovelvariantofthrbandits4yearclinicalcourseinakoreanboywithresistancetothyroidhormone
AT sejinkim novelvariantofthrbandits4yearclinicalcourseinakoreanboywithresistancetothyroidhormone
AT soyunpark novelvariantofthrbandits4yearclinicalcourseinakoreanboywithresistancetothyroidhormone
AT jungeunmoon novelvariantofthrbandits4yearclinicalcourseinakoreanboywithresistancetothyroidhormone
AT heungsikkim novelvariantofthrbandits4yearclinicalcourseinakoreanboywithresistancetothyroidhormone
AT seokjinkang novelvariantofthrbandits4yearclinicalcourseinakoreanboywithresistancetothyroidhormone